The monoclonal antibody revolution has produced a wave of important new therapeutics, but developing effective antibodies remains elusive for many targets and indications. The discovery and ...

Please provide your email address to receive an email when new articles are posted on . The two highest doses of REGN5459 conferred a 90.5% objective response rate. Low-affinity binding may lead to ...

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles is proud to announce the launch of its new line of Alkali-Tolerant AAV Affinity Agarose Resins. Specifically ...